These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23858964)

  • 1. Nanosponges encapsulating dexamethasone for ocular delivery: formulation design, physicochemical characterization, safety and corneal permeability assessment.
    Swaminathan S; Vavia PR; Trotta F; Cavalli R
    J Biomed Nanotechnol; 2013 Jun; 9(6):998-1007. PubMed ID: 23858964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity.
    Swaminathan S; Pastero L; Serpe L; Trotta F; Vavia P; Aquilano D; Trotta M; Zara G; Cavalli R
    Eur J Pharm Biopharm; 2010 Feb; 74(2):193-201. PubMed ID: 19900544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study.
    Ansari KA; Vavia PR; Trotta F; Cavalli R
    AAPS PharmSciTech; 2011 Mar; 12(1):279-86. PubMed ID: 21240574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
    Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
    Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
    Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y
    Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Nanoparticle-Based Ophthalmic Formulation of Dexamethasone Enhances Corneal Permeability of the Drug and Prolongs Its Corneal Residence Time.
    Nagai N; Nakazawa Y; Ito Y; Kanai K; Okamoto N; Shimomura Y
    Biol Pharm Bull; 2017; 40(7):1055-1062. PubMed ID: 28674248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucoadhesive dexamethasone-glycol chitosan nanoparticles for ophthalmic drug delivery.
    Yu A; Shi H; Liu H; Bao Z; Dai M; Lin D; Lin D; Xu X; Li X; Wang Y
    Int J Pharm; 2020 Feb; 575():118943. PubMed ID: 31830575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking.
    Conde Penedo A; Díaz Tomé V; Fernández Ferreiro A; González Barcia M; Otero Espinar FJ
    Eur J Pharm Biopharm; 2021 May; 162():12-22. PubMed ID: 33667681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential nanoparticle-loaded in situ gel for enhanced and sustained ophthalmic delivery of dexamethasone.
    Wen Y; Ban J; Mo Z; Zhang Y; An P; Liu L; Xie Q; Du Y; Xie B; Zhan X; Tan L; Chen Y; Lu Z
    Nanotechnology; 2018 Oct; 29(42):425101. PubMed ID: 30074486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
    Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
    J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
    Katara R; Majumdar DK
    Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. yCD/HPyCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension.
    Jansook P; Ritthidej GC; Ueda H; Stefánsson E; Loftsson T
    J Pharm Pharm Sci; 2010; 13(3):336-50. PubMed ID: 21092707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
    Kalam MA
    Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
    Liu R; Liu Z; Zhang C; Zhang B
    J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of cyclodextrin-based nanosponges of griseofulvin as pediatric oral liquid dosage form for enhancing bioavailability and masking bitter taste.
    Omar SM; Ibrahim F; Ismail A
    Saudi Pharm J; 2020 Mar; 28(3):349-361. PubMed ID: 32194337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation Optimization and Biopharmaceutical Evaluation of Imatinib Mesylate Loaded β-cyclodextrin Nanosponges.
    Kamble M; Zaheer Z; Mokale S; Zainuddin R
    Pharm Nanotechnol; 2019; 7(5):343-361. PubMed ID: 31549599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation.
    Huang J; Peng T; Li Y; Zhan Z; Zeng Y; Huang Y; Pan X; Wu CY; Wu C
    AAPS PharmSciTech; 2017 Nov; 18(8):2919-2926. PubMed ID: 28429294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel sulpiride-loaded solid lipid nanoparticles with enhanced intestinal permeability.
    Ibrahim WM; AlOmrani AH; Yassin AE
    Int J Nanomedicine; 2014; 9():129-44. PubMed ID: 24379671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
    Shende PK; Gaud RS; Bakal R; Patil D
    Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation of Azithromycin Ion Pair in Liposome for Enhancing Ocular Delivery and Therapeutic Efficacy on Dry Eye.
    Ren T; Lin X; Zhang Q; You D; Liu X; Tao X; Gou J; Zhang Y; Yin T; He H; Tang X
    Mol Pharm; 2018 Nov; 15(11):4862-4871. PubMed ID: 30251864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.